Cognitive Task Performance During Fatigue
Trial Summary
What is the purpose of this trial?
This trial will study how doing a mental task affects muscle fatigue during exercise. It involves general individuals and aims to see if mental effort changes how tired muscles get.
Do I need to stop taking my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Cognitive Task, Cognitive Training, Cognitive Remediation, Cognitive Rehabilitation, Cognitive Stimulation Therapy?
Research shows that cognitive rehabilitation, which includes cognitive training and remediation, is effective in improving attention, memory, and other cognitive functions in patients with brain injuries and multiple sclerosis. Studies have demonstrated significant improvements in cognitive performance and everyday behaviors after using computer-assisted cognitive training programs.12345
Is cognitive training safe for humans?
Cognitive training, used in various conditions like brain injury and cancer, is generally safe for humans. Some studies noted minor side effects such as mental fatigue, headache, and eye irritation, but overall, participants showed improved cognitive functions without significant safety concerns.16789
How does this treatment for cognitive task performance during fatigue differ from other treatments?
This treatment is unique because it focuses on cognitive training using a novel game called 'Decoder' on an iPad, which enhances attention without medication. Unlike traditional drug treatments like methylphenidate, which is used for mental fatigue after brain injury, this approach is non-pharmacological and aims to improve sustained attention through engaging and motivating tasks.1011121314
Research Team
Hugo Pereira, PhD
Principal Investigator
University of Oklahoma
Eligibility Criteria
This trial is for healthy individuals in two age groups: young adults aged 18-35 and older adults aged 65-90. It's not suitable for those with neuromuscular diseases or anyone who has metal implants or joint replacements.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Familiarization
Participants undergo a familiarization session to get accustomed to the experimental procedures
Experimental Sessions
Participants engage in 3 randomized experimental sessions to assess force, anxiety levels, arterial pressure, and fatigue
Follow-up
Participants are monitored for any delayed effects or additional data collection after the experimental sessions
Treatment Details
Interventions
- Cognitive Task (Behavioral Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Oklahoma
Lead Sponsor
Dr. Scott Rollins
University of Oklahoma
Chief Executive Officer since 2016
PhD in Immunology from the University of Oklahoma
Dr. Ondria Gleason
University of Oklahoma
Chief Medical Officer
MD from the University of Oklahoma College of Medicine